XNAS · ANIK

-1.43% · -$0.2800 · Vol 95.2K

After hours · updated 16:30:45 ET

Anika Therapeutics Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

$19.33

Card

Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factors

Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET · ANIK

Methodology

ANIK

Anika Therapeutics Inc

Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET

79/100

STRONG

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

79/ 100

Veridion Score

STRONG · HIGH confidence

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 6/6 factors with data · Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is ANIK moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move ANIK next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Aug 4
Score
Score moved +53
26/AVOID -> 79/STRONG
Veridion score historySource
Mar 2
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Feb 28
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Feb 27
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Feb 26
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jan 28
CongressChecking access
Tom Malinowski sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Oct 29
CongressChecking access
Tom Malinowski sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Aug 1
CongressChecking access
Tom Malinowski purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jul 29
CongressChecking access
Tom Malinowski sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

About Anika Therapeutics Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Listed since

1993

Employees

235

Country

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$19.64

Day high

$19.68

Day low

$19.00

Previous close

$19.61

52W high